Tissue engineering application on coronavirus (Covid-19) Pandemic: A review
DOI:
https://doi.org/10.60141/AJID/V.2.I.1.6Keywords:
COVID-19, Tissue engineering, BiomaterialsAbstract
Background: The use of biomaterials in diagnosing and treating COVID-19 has been investigated in various forms and origins, including natural and synthetic materials. The development of rapid and highly sensitive biosensors based on field-effect transistors and the creation of antiviral platforms, vaccines, and nanomaterials have been the focus of most research on the application of biomaterials. Tissue engineering encompasses the study of tissue development, behavior, and growth factors that are more readily supported in the medical setting. This paper reviews the roles of biomaterials, tissue engineering, drug delivery, microfluidics, and 3D printing technologies in urgently responding to pandemics like COVID-19. In addition, this research covers a broad area of vaccines and treatments, reviewing the most promising candidate drugs and vaccines that have entered clinical trials to date. These engineering methods focus on biomaterials, drug delivery systems, and replacing damaged tissues and organs. Some biodegradable biomaterials, such as chitosan, mesoporous silica rods, and PLGA nanoparticles, have been utilized as vaccine platforms and can be employed in developing a SARS-CoV-2 vaccine. Notably, the proposed platform's size, shape, and other physicochemical characteristics should be carefully planned to achieve the desired effects on the immune system.
Conclusion: Tissue engineers possess unique tools that can significantly advance our understanding of viral illnesses and aid in creating diagnostic and therapeutic platforms. Future research on COVID-19 infection and drug testing will benefit significantly from developing organ-on-a-chip technologies. Developing innovative biomaterial-based techniques for preventing, treating, and monitoring COVID-19 requires collaboration across multiple disciplines.
References
Tatara AM. Role of Tissue Engineering in COVID-19 and Future Viral Outbreaks. Tissue Engineering Part A.26:468-74.
Tatara AM. Role of tissue engineering in COVID-19 and future viral outbreaks. Tissue Engineering Part A. 2020; 26(9-10):468-74.
Chakraborty J. Bioengineered in Vitro Tissue Models to Study SARS-CoV-2 Pathogenesis and Therapeutic Validation. ACS Biomaterials Science & Engineering.6 (12):6540-55.
Baral PK. Treatment and prevention strategies for the COVID 19 pandemic: A review w of immunotherapeutic approaches for neutralizing SARS-CoV-2. International Journal of Biological Macromolecules.186:490-500.
Zhao Z. Targeting Strategies for Tissue-Specific Drug Delivery. Cell.181 (1):151-67.
Ostergaard L. SARS CoV-2 related microvascular damage and symptoms during and after COVID-19: Consequences of capillary transit-time changes, tissue hypoxia and inflammation. Physiological Reports.9 (3).
Pan Y. Re-thinking of engineering operation solutions to HVAC systems under the emerging COVID-19 pandemic. Journal of building engineering.43:102889-.
Melchor-Martínez EM, Torres Castillo NE, Macias-Garbett R, Lucero-Saucedo SL, Parra-Saldívar R, Sosa-Hernández JE. Modern world applications for nano-bio materials: tissue engineering and COVID-19. Frontiers in Bioengineering and Biotechnology. 2021; 9:597958.
de Oliveira Viana IM. Innate and adaptive immune responses toward nanomedicines. Acta Pharmaceutica Sinica B.11 (4):852-70.
Softa A, Bahl S, Bagha AK, Sehgal S, Haleem A, Javaid M. Tissue engineering and its significance in healthcare during COVID-19 pandemic: potential applications and perspectives. Journal of Industrial Integration and Management. 2021;6(02):221-33.
Eibl R. Application of Disposable Bag-Bioreactors in Tissue Engineering and fo r the Production of Therapeutic Agents. Advances in Biochemical Engineering / Biotechnology.112:183-207.
Shafiee A. Coronavirus disease 2019: A tissue engineering and regenerative medicine perspective. Stem Cells Translational Medicine.10 (1):27-38.
Ou KL. Development of 3D in vitro technology for medical applications. International Journal of Molecular Sciences.15 (10):17938-62.
Lantigua D. Synthesis and characterization of photocrosslinkable albumin-based hyd rogels for biomedical applications. Soft Matter.16 (40):9242-52.
Paranjpe M. Nanoparticle-Mediated Pulmonary Drug Delivery: A Review. International Journal of Molecular Sciences.15 (4):5852-73.
Khatoon N. Nanoclay-based drug delivery systems and their therapeutic potentials. Journal of Materials Chemistry B.8 (33):7335-51.
Shafiee A, Moradi L, Lim M, Brown J. Coronavirus disease 2019: a tissue engineering and regenerative medicine perspective. Stem Cells Translational Medicine. 2021; 10(1):27-38.
Zhang YS. Seeking the right context for evaluating nanomedicine: from tissue models in petri dishes to microfluidic organs-on-a-chip. Nanomedicine: Nanotechnology, Biology and Medicine.10 (5):685-8.
Shafiee A, Moradi L, Lim M, Brown J. Stem Cells Transl. Med. 2021;10(27):10.1002.
Lawko N, Plaskasovitis C, Stokes C, Abelseth L, Fraser I, Sharma R, et al. 3D tissue models as an effective tool for studying viruses and vaccine development. Frontiers in Materials. 2021:80.
Melchor-Martínez EM. Modern World Applications for Nano-Bio Materials: Tissue Engineering and COVID-19. Frontiers in Bioengineering and Biotechnology.9:597958-.
Parihar A, Pandita V, Khan R. 3D printed human or ganoids: High throughput system for drug screening and testing in current COVID‐19 pandemic. Biotechnology and Bioengineering. 2022; 119(10):2669-88.
de Dios-Figueroa GT, Aguilera-Marquez JdR, Camacho-Villegas TA, Lugo-Fabres PH. 3d cell culture models in covid-19 times: A review of 3D technologies to understand and accelerate therapeutic drug discovery. Biomedicines. 2021;9(6):602.
Gomathi S. Pattern analysis: predicting COVID-19 pandemic in India using AutoML. World Journal of Engineering.
Ahmed TA, Eldaly B, Eldosuky S, Elkhenany H, El-Derby AM, Elshazly MF, et al. The interplay of cells, polymers, and vascularization in three-dimensional lung models and their applications in COVID-19 research and therapy. Stem Cell Research & Therapy. 2023; 14(1):114.
Kabir A, Datta P, Oh J, Williams A, Ozbolat V, Unutmaz D, et al. 3D Bioprinting for fabrication of tissue models of COVID-19 infection. Essays in biochemistry. 2021; 65(3):503-18.
Eckel F. Variplex™ test system fails to reliably detect SARS-CoV-2 directly from respiratory samples without RNA extraction. European Journal of Clinical Microbiology & Infectious Diseases.39 (12):2373-7.
Vithani K. An Overview of 3D Printing Technologies for Soft Materials and Potential Opportunities for Lipid-based Drug Delivery Systems. Pharmaceutical Research.36 (1):4-.
Tappa K. Novel Biomaterials Used in Medical 3D Printing Techniques. Journal of Functional Biomaterials.9 (1):1.
Cheng L. 3D Printing of Micro- and Nanoscale Bone Substitutes: A Review on Technical and Translational Perspectives. International Journal of Nanomedicine.16:4289-319.
Cui M. Opportunities and challenges of three-dimensional printing technology in pharmaceutical formulation development. Acta Pharmaceutica Sinica B.11 (8):2488-504.
Nazir A. The rise of 3D Printing entangled with smart computer aided design during COVID-19 era. Journal of Manufacturing Systems.60:774-86.
Salerno A. Review on Computer-Aided Design and Manufacturing of Drug Delivery Scaffolds for Cell Guidance and Tissue Regeneration. Frontiers in Bioengineering and Biotechnology.9:682133-.
Aydin A, Cebi G, Demirtas ZE, Erkus H, Kucukay A, Ok M, et al. Combating COVID-19 with tissue engineering: a review. Emergent Materials. 2021; 4:329-49.
Rao V. Mesenchymal stem cells-bridge catalyst between innate and adaptive imm unity in COVID 19. Medical Hypotheses.143:0.
Abbas M, Alqahtani MS, Almohiy HM, Alqahtani FF, Alhifzi R, Jambi LK. The potential contribution of biopolymeric particles in lung tissue regeneration of COVID-19 Patients. Polymers. 2021; 13(22):4011.
Jalise SZ, Baheiraei N, Bagheri F. The effects of strontium incorporation on a novel gelatin/bioactive glass bone graft: In vitro and in vivo characterization. Ceramics International. 2018; 44(12):14217-27.
Tandon B. Electroactive biomaterials: Vehicles for controlled delivery of therap eutic agents for drug delivery and tissue regeneration. Advanced Drug Delivery Reviews.129:148-68.
Mokhtari F. Recent advances of polymer-based piezoelectric composites for biomedic al applications. Journal of the Mechanical Behavior of Biomedical Materials.122:0.
Colombani T, Rogers ZJ, Eggermont LJ, Bencherif SA. Harnessing biomaterials for therapeutic strategies against COVID-19. Emergent Materials. 2021; 4:9-18.
Chakhalian D, Shultz RB, Miles CE, Kohn J. Opportunities for biomaterials to address the challenges of COVID‐19. Journal of Biomedical Materials Research Part A. 2020; 108(10):1974-90.
Van Bochove B. Photo-crosslinked synthetic biodegradable polymer networks for biomedical applications. Journal of Biomaterials Science-polymer Edition.30 (2):77-106.
Zhang K. Advanced smart biomaterials and constructs for hard tissue engineering and regeneration. Bone research.6 (1):31-.
Wierzbicki J. Additive manufacturing technologies enabling rapid and interventional production of protective face shields and masks during the COVID-19 pa ndemic. Advances in Clinical and Experimental Medicine.29 (9):1021-8.
Reddy MSB. A Comparative Review of Natural and Synthetic Biopolymer Composite Scaffolds. Polymers.13 (7):7.
Chakhalian D. Opportunities for biomaterials to address the challenges of COVID-19. Journal of Biomedical Materials Research Part A.108 (10):1974-90.
Bindoli S. The amount of cytokine-release defines different shades of Sars-Cov2 infection. Experimental Biology and Medicine.245 (11):970-6.
Gelmi A. Stimuli-Responsive Biomaterials: Scaffolds for Stem Cell Control. Advanced Healthcare Materials.10 (1):1.
Derakhshanfar S. 3D bioprinting for biomedical devices and tissue engineering: A review of recent trends and advances. Bioactive Materials.3 (2):144-56.
Aguilar-de-Leyva Á. 3D Printed Drug Delivery Systems Based on Natural Products. Pharmaceutics.12 (7):7.
Elalouf A. Immune response against the biomaterials used in 3D bioprinting of org ans. Transplant Immunology.69:0.
Matai I. Progress in 3D bioprinting technology for tissue/organ regenerative en gineering. Biomaterials.226:119536-.
Joyce K. Bioactive potential of natural biomaterials: identification, retention and assessment of biological properties. Signal Transduction and Targeted Therapy.6 (1):122-.
Laghrib F, Saqrane S, El Bouabi Y, Farahi A, Bakasse M, Lahrich S, et al. Current progress on COVID-19 related to biosensing technologies: New opportunity for detection and monitoring of viruses. Microchemical Journal. 2021; 160:105606.
Parihar A, Ranjan P, Sanghi SK, Srivastava AK, Khan R. Point-of-care biosensor-based diagnosis of COVID-19 holds promise to combat current and future pandemics. ACS applied bio materials. 2020; 3(11):7326-43.
Spolverato G. The management of surgical patients during the coronavirus disease 201 9 (COVID-19) pandemic. Surgery.168 (1):4-10.
Verma N, Patel D, Pandya A. Emerging diagnostic tools for detection of COVID-19 and perspective. Biomedical microdevices. 2020;22 (4):83.
Eissa S. Voltammetric-based immunosensor for the detection of SARS-CoV-2 nucleocapsid antigen. Mikrochimica Acta.188 (6):199-.
Balkourani G. Emerging materials for the electrochemical detection of COVID-19. Journal of Electroanalytical Chemistry.893:115289-.
Mobed A. Biosensors promising bio-device for pandemic screening "COVID-19". Microchemical Journal.164:106094-.
Sharma D. Updates on clinical trials evaluating the regenerative potential of al logenic mesenchymal stem cells in COVID-19. npj Regenerative Medicine.6(1):37-.
Lahiri D. Neuroinvasive potential of a primary respiratory pathogen SARS- CoV2: Summarizing the evidences. Diabetes and Metabolic Syndrome: Clinical Research and Reviews.14 (5):1053-60.
Julier Z. Promoting tissue regeneration by modulating the immune system. Acta Biomaterialia.53:13-28.
Zhu F-j. Role of dendritic cells in the host response to biomaterials and their signaling pathways. Acta Biomaterialia.94:132-44.
Benne N. Orchestrating immune responses: How size, shape and rigidity affect th e immunogenicity of particulate vaccines. Journal of Controlled Release.234:124-34.
Gu P. Polyethylenimine-coated PLGA nanoparticles-encapsulated Angelica sinensis polysaccharide as an adjuvant to enhance immune responses. Carbohydrate Polymers.223:0.
Jahan ST. Potentiating Antigen Specific Immune Response by Targeted Delivery of the PLGA-Based Model Cancer Vaccine. Molecular Pharmaceutics.16 (2):498-509.
Svindland S. A study of Chitosan and c-di-GMP as mucosal adjuvants for intranasal influenza H5N1 vaccine. Influenza and Other Respiratory Viruses.7 (6):1181-93.
Carazo S. Effect of age at vaccination on the measles vaccine effectiveness and immunogenicity: systematic review and meta-analysis. BMC Infectious Diseases.20 (1):1-18.
Baino F. Bioactive glass-based materials with hierarchical porosity for medical applications: review of recent advances. Acta Biomaterialia.42:18-32.
Lee SJ. Scaffold technologies for controlling cell behavior in tissue engineer ing. Biomedical Materials.8 (1):10201-.
Soh JH. Strategies for developing sensitive and specific nanoparticle-based lateral flow assays as point-of-care diagnostic device. Nano Today.30:0.
Ren H. Multiplexed serpentine microchannels for high-throughput sorting of disseminated tumor cells from malignant pleural effusion. Sensors and Actuators B-chemical.337:0.
Dai B. A flux-adaptable pump-free microfluidics-based self-contained platform for multiplex cancer biomarker detection. Lab on a Chip.21 (1):143-53.
Lin Q. Microfluidic Immunoassays for Sensitive and Simultaneous Detection of IgG/IgM/Antigen of SARS-CoV-2 within 15 min. Analytical Chemistry.92 (14):9454-8.
Ramachandran A. Electric field-driven microfluidics for rapid CRISPR-based diagnostics and its application to detection of SARS-CoV-2. Proceedings of the National Academy of Sciences of the United States of America.117 (47):29518-25.
Machhi J. A Role for Extracellular Vesicles in SARS-CoV-2 Therapeutics and Prevention. Journal of Neuroimmune Pharmacology.16 (2):1-19.
Polz-Dacewicz M. Novel coronavirus - SARS CoV-2. Polish Journal of Public Health.129 (4):113-7.
Prajapati SK. An update on novel COVID-19 pandemic: a battle between humans and virus. European Review for Medical and Pharmacological Sciences.24 (10):5819-29.
